Akshay Vaishnaw
Publications by Year
Research Areas
Amyloidosis: Diagnosis, Treatment, Outcomes, RNA Interference and Gene Delivery, Respiratory viral infections research, Alzheimer's disease research and treatments, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis(2018)2,831 cited
- → Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis(2013)955 cited
- → A Highly Durable RNAi Therapeutic Inhibitor of PCSK9(2016)740 cited
- → First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement(2013)692 cited
- → A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis(2003)611 cited
- → Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria(2020)572 cited
- → Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial(2013)571 cited
- → FasGene Mutations in the Canale–Smith Syndrome, an Inherited Lymphoproliferative Disorder Associated with Autoimmunity(1996)481 cited
- → Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1(2021)476 cited
- → Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis(2019)458 cited